Delee

DeleeBlood testing device for early diagnosis of cancer and treatment…

Delee's blood-testing device revolutionizes cancer detection and monitoring. Our technology isolates and analyzes circulating tumor cells for early diagnosis and treatment efficacy tracking.

Delee screenshot

Delee

Delee provides the CytoCatchâ„¢ technology, the perfect solution for isolating and analyzing circulating tumor cells (CTCs) with high accuracy and efficiency. It's a best-in-class solution, providing highly accurate and consistent results, thanks to its fully automated design.

Product Highlights

  • Accurate and Automated CTC Isolation: The CytoCatchâ„¢ technology achieves outstanding recovery rates, above 97% when using multiple cancer cell lines, making it the ideal tool for researchers
  • Accurate Imaging and Analysis of CTCs: The CytoCatchâ„¢ technology delivers highly accurate CTC enumeration using advanced machine learning and computer vision algorithms, along with complete device customization to ensure optimal results
  • Unparalleled Experiment Flexibility: The CytoCatchâ„¢ technology allows you to customize your own protocols and choose the antibodies, fluorophores, and staining strategies that best fit your needs, giving you complete control over experiments

Use Cases

  • Early Cancer Detection: The CytoCatchâ„¢ technology enables scientists to detect cancer at its early stages by analyzing CTCs in blood
  • Monitoring Disease Progression: Researchers can track cancer progression and assess treatment effectiveness using the CytoCatchâ„¢ technology for CTC analysis
  • Drug Research: Scientists can leverage the CytoCatchâ„¢ technology to develop new drugs and test their effectiveness on CTCs

Target Audience

The CytoCatchâ„¢ technology is ideal for scientists and researchers in the fields of oncology and molecular biology, providing advanced tools to work with CTCs.